Click here to read the articles and view the interactive digital edition

Pharmaceutical Commerce - November 2025

Cencora executive Heather Zenk discusses how innovations in cold chain, data visibility, and sustainability strategies are transforming the drug delivery process.

Building Resilient, Sustainable Pharma Supply Chains

From patent cliffs and government price controls, to self-pay models and staff-model HMOs, a look at the forces that could deflate the bubble—and those factors likely to keep it afloat a while longer.

Popping the Gross-to-Net Bubble, Part VI: The Future of Pharmaceutical Pricing

Advice for pharma distributors and dispensers on what they should do now in order to solidify a secure supply chain.

DSCSA Compliance: Milestones, More Deadlines—and the Road Ahead

. He can be reached at nsaraceno@mjhlifesciences.com.

Articles

The 200,000 square-foot Madison, WI facility will serve as the flagship location, with capabilities for future growth. 

TekniPlex Healthcare Unveils New Barrier Protection Systems Plant

The June issue of Pharmaceutical Commerce highlights the importance of embracing agility—and adaptable strategies—to better navigate industry challenges.

The Art of Agility

Videos

In the second part of her Pharma Commerce video interview, LeAnn Boyd, Liviniti’s founder and CEO, discusses how this MFN executive order can affect players in the space that operate under a rebate-driven PBM model. 

Moving Beyond the Rebate-Driven Model

Pharma Pulse 6/18/25: The Complexities of Drug Discounting; How Clinical Operations Teams Are Adapting to Oncology Trial Challenges

A professor of food, pharma, and healthcare business at Saint Joseph’s University’s Erivan K. Haub School of Business.

Ways to address limitations while also enhancing the decision-making process.


Bolstering Health Technology Assessment With the Help of AI

Executive Director of the Otsuka Patient Assistance Foundation, Inc. (OPAF)

The advantages and challenges associated with structuring a patient assistance 
program as a non-profit foundation.

Changing the PAP Model 

Though this specific agreement centers around aerospace and automobiles, the greater supply chain will wait and see how Trump’s import taxes impact pharmaceuticals, a sector that faces a potential 25% tax on imports.

United States, United Kingdom Reach Tariff-Lowering Deal

Approaches powered by RWD can clear the way for a greater focus on patient-centered care.

Building Intelligent Pharma Supply Chain Management with Real-World Data

In the first part of her Pharma Commerce video interview, LeAnn Boyd, Liviniti’s founder and CEO, outlines the most critical root causes of rising healthcare and drug costs that the MFN executive order doesn’t address.

Featured Content

Pharmaceutical Commerce - November 2025

Building Resilient, Sustainable Pharma Supply Chains

Popping the Gross-to-Net Bubble, Part VI: The Future of Pharmaceutical Pricing

DSCSA Compliance: Milestones, More Deadlines—and the Road Ahead